(Q39281785)

10 September 2017

title

Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo (English)

1 reference

10 September 2017

1 reference

1 reference

7

Michael Baumann

1 reference

10 September 2017

10

Leoni A Kunz-Schughart

1 reference

10 September 2017

Susann Peickert

1

1 reference

10 September 2017

Julia Waurig

2

1 reference

10 September 2017

Claudia Dittfeld

3

1 reference

10 September 2017

Antje Dietrich

4

1 reference

10 September 2017

Yvette Garbe

5

1 reference

10 September 2017

Lydia Kabus

6

1 reference

10 September 2017

Marian Grade

8

1 reference

10 September 2017

Thomas Ried

9

1 reference

10 September 2017

publication date

10 September 2012

1 reference

10 September 2017

published in

Laboratory Investigation

1 reference

10 September 2017

volume

92

1 reference

10 September 2017

issue

11

1 reference

10 September 2017

page(s)

1607-1622

1 reference

describes a project that uses

10 September 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC7477948/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Estimates of cancer incidence and mortality in Europe in 2008.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Colon cancer stem cells: promise of targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells: markers or biomarkers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The cancer stem cell hypothesis: in search of definitions, markers, and relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells: a step toward the cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Colon cancer stem cells: implications for prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells in solid tumors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133+CD44+ population efficiently enriches colon cancer initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Biological and genetic characteristics of tumor-initiating cells in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Characteristics of CD133(+) human colon cancer SW620 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Spheroid-based drug screen: considerations and practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The percentage of CD133+ cells in human colorectal cancer cell lines is influenced by Mycoplasma hyorhinis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Genome and transcriptome profiles of CD133-positive colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 expression in rectal cancer after preoperative chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 expression predicts for non-response to chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Clinical Significance of CD133 and Hypoxia Inducible Factor-1α Gene Expression in Rectal Cancer after Preoperative Chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Immunohistochemical features of CD133 expression: association with resistance to chemoradiotherapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 as a marker for cancer stem cells: progresses and concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Quantitative analyses of CD133 expression facilitate researches on tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 is a marker of bioenergetic stress in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells as a predictive factor in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

Cancer stem cells from colorectal cancer-derived cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

21 January 2018

1 reference

12 December 2020

Molecular identification and targeting of colorectal cancer stem cells

1 reference

12 December 2020

Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133

1 reference

12 December 2020

Colon cancer stem cells

1 reference

12 December 2020

A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning

1 reference

12 December 2020

Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations

1 reference

12 December 2020

Divergent expression of CD133 in different studies: the need for a consensus panel?

1 reference

12 December 2020

Is CD133 a marker of metastatic colon cancer stem cells?

1 reference

12 December 2020

Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer

1 reference

12 December 2020

Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.124

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/LABINVEST.2012.124

1 reference

release_6erptx6uyne6hhh7je4im4z75e

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6erptx6uyne6hhh7je4im4z75e

24 November 2022

mapped directly with Wikidata item

PMC publication ID

7477948

0 references

1 reference